Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Apple
AAPL
|
+$3.05B |
| 2 |
Broadcom
AVGO
|
+$1.54B |
| 3 |
NVIDIA
NVDA
|
+$1.43B |
| 4 |
Microsoft
MSFT
|
+$1.3B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.66B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.21B |
| 3 |
Imperial Oil
IMO
|
+$797M |
| 4 |
Vale
VALE
|
+$561M |
| 5 |
Canadian Natural Resources
CNQ
|
+$543M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Financials | 9.79% |
| 3 | Healthcare | 8.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
AllianceBernstein
AB
$4.19B
| $2.04M | ﹤0.01% |
60,255
-9,912
| -14% | -$335K |
|
3152
First Trust Exchange-Traded Fund VI First Trust Dorsey Wright Momentum & Dividend ETF
DDIV
$67.4M
| $2.03M | ﹤0.01% |
60,635
+15,619
| +35% | +$524K |
|
3153
Esperion Therapeutics
ESPR
$573M
| $2.03M | ﹤0.01% |
916,011
-2,448,255
| -73% | -$5.44M |
|
3154
Kornit Digital
KRNT
$647M
| $2.03M | ﹤0.01% |
138,439
+72,289
| +109% | +$1.06M |
|
3155
Ryerson Holding
RYI
$723M
| $2.03M | ﹤0.01% |
103,926
-35,439
| -25% | -$691K |
|
3156
MacroGenics
MGNX
$100M
| $2.03M | ﹤0.01% |
476,526
+130,201
| +38% | +$553K |
|
3157
Design Therapeutics
DSGN
$343M
| $2.02M | ﹤0.01% |
603,705
+97,449
| +19% | +$326K |
|
3158
iShares MSCI Philippines ETF
EPHE
$103M
| $2.02M | ﹤0.01% |
83,489
| – | – |
|
3159
Vanda Pharmaceuticals
VNDA
$266M
| $2.01M | ﹤0.01% |
356,546
-148,839
| -29% | -$841K |
|
3160
Camden National
CAC
$684M
| $2.01M | ﹤0.01% |
61,026
+22,324
| +58% | +$737K |
|
3161
iShares MSCI Chile ETF
ECH
$713M
| $2.01M | ﹤0.01% |
77,825
| – | – |
|
3162
eHealth
EHTH
$122M
| $2.01M | ﹤0.01% |
442,638
+365,581
| +474% | +$1.66M |
|
3163
iShares US Infrastructure ETF
IFRA
$3B
| $2M | ﹤0.01% |
47,594
-9,167
| -16% | -$386K |
|
3164
CPI Card Group
PMTS
$169M
| $2M | ﹤0.01% |
73,460
-78,912
| -52% | -$2.15M |
|
3165
Liquidia Corp
LQDA
$2.24B
| $2M | ﹤0.01% |
166,570
-97,891
| -37% | -$1.17M |
|
3166
J. Jill
JILL
$273M
| $2M | ﹤0.01% |
57,116
+43,144
| +309% | +$1.51M |
|
3167
Financial Institutions
FISI
$545M
| $2M | ﹤0.01% |
103,362
+1,018
| +1% | +$19.7K |
|
3168
Calvert US Mid-Cap Core Responsible Index ETF
CVMC
$79.6M
| $2M | ﹤0.01% |
36,204
+22,966
| +173% | +$1.27M |
|
3169
Absci
ABSI
$381M
| $1.99M | ﹤0.01% |
645,589
-56,048
| -8% | -$173K |
|
|
EFC
3170
Ellington Financial
EFC
$1.34B
| $1.99M | ﹤0.01% |
164,570
+57,978
| +54% | +$700K |
|
3171
Karyopharm Therapeutics
KPTI
$55.9M
| $1.99M | ﹤0.01% |
152,696
+52,145
| +52% | +$679K |
|
3172
Astec Industries
ASTE
$1.06B
| $1.98M | ﹤0.01% |
66,842
+16,705
| +33% | +$495K |
|
3173
VanEck Steel ETF
SLX
$82.3M
| $1.98M | ﹤0.01% |
29,757
+13,903
| +88% | +$926K |
|
3174
Galapagos
GLPG
$2.11B
| $1.98M | ﹤0.01% |
79,835
-11,650
| -13% | -$289K |
|
3175
Cerence
CRNC
$450M
| $1.98M | ﹤0.01% |
698,727
+540,233
| +341% | +$1.53M |
|